Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Abnormal Expression of B7-H4 Is Associated With the Pathogenesis of Autoimmune Thyroid Diseases. | J Immunol Res | 2026 | 41811839 | PubTator, text mining | PubMed |
| CircEif3c/miR-96-5p/PHF20L1/MEOX2 axis in perivascular preadipocyte exosomes mediates fibroblast dysfunction and vascular remodeling. | Noncoding RNA Res | 2026 | 41809968 | PubTator, text mining | PubMed |
| Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients. | Front Oncol | 2026 | 41809822 | PubTator, text mining | PubMed |
| Neoadjuvant immunochemotherapy in potentially resectable small cell lung cancer: a real-world retrospective analysis. | Transl Lung Cancer Res | 2026 | 41808721 | PubTator, text mining | PubMed |
| Research progress on resistance mechanisms to CAR-T cell therapy in diffuse large B-cell lymphoma. | Front Oncol | 2026 | 41800035 | PubTator, text mining | PubMed |
| The Th17/Treg axis: a key to understanding and treating autoimmune disorders. | Open Life Sci | 2026 | 41799642 | PubTator, text mining | PubMed |
| SMPD1 as a Potential Prognostic Biomarker in Glioma Is Associated With an Immunosuppressive Microenvironment. | CNS Neurosci Ther | 2026 | 41795144 | PubTator, text mining | PubMed |
| Interleukin-30 promotes melanoma spreading and triggers LAG-3 expression and T cell exhaustion. | Biomed Pharmacother | 2026 | 41793972 | PubTator, text mining | PubMed |
| SWI/SNF-associated molecular subtypes reshape tumor microenvironmental features and inform precision therapeutic strategies in bladder cancer. | Front Cell Infect Microbiol | 2026 | 41789425 | PubTator, text mining | PubMed |
| Spatial transcriptomics and artificial intelligence: a scoping review of emerging applications in head and neck pathology. | Head Neck Pathol | 2026 | 41779110 | PubTator, text mining | PubMed |
| Research Progress on Tumor-Associated Macrophages and PD-1/PD-L1 Inhibitors in Advanced Colorectal Cancer. | Cancer Control | 2026 | 41769787 | PubTator, text mining | PubMed |
| Poliovirus receptor (PVR) expression as a predictor of relapse in colorectal cancer: bioinformatics and virtual screening. | Exp Biol Med (Maywood) | 2026 | 41767749 | PubTator, text mining | PubMed |
| Sex Differences in Cancer Immunotherapy-Clinical Evidence and Mechanisms With a Focus on NSCLC. | Immunol Rev | 2026 | 41761458 | PubTator, text mining | PubMed |
| Novel advances in juvenile idiopathic arthritis associated uveitis. | Arthritis Res Ther | 2026 | 41761332 | PubTator, text mining | PubMed |
| Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy. | Pharmaceuticals (Basel) | 2026 | 41754865 | PubTator, text mining | PubMed |
| Immunosuppressive Environment of Pancreatic NENs-A Review. | Biomedicines | 2026 | 41751264 | PubTator, text mining | PubMed |
| Emerging Protein Targets in Triple-Negative Breast Cancer: Beyond Conventional Therapy. | Cancers (Basel) | 2026 | 41749871 | PubTator, text mining | PubMed |
| Targeting Biliary Tract Cancers with Antibody-Drug Conjugates: Advances in Molecular Targets and Rational Combinations. | Cancers (Basel) | 2026 | 41749852 | PubTator, text mining | PubMed |
| Predicting skin melanoma progression via LAG-3, TIGIT and HAVCR2. | Funct Integr Genomics | 2026 | 41746432 | PubTator, text mining | PubMed |
| Trop2-Based Antibody-Drug Conjugates: Emerging Strategy and Progress in Triple-Negative Breast Cancer Therapy. | Curr Oncol | 2026 | 41744856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=3